Patent ID: 11970482
Assignee: LIGAND PHARMACEUTICALS INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 22:
23. The compound of claim 22, wherein R21 is selected from the group consisting of C1-6a1kyl, halo, cyano, hydroxyl, C1-6alkoxy, halo C1-6alkyl, halo C16alkoxy, nitro, —C(=O)NR22R23, —N(R24)C(=O)R25, —C(=O)OR26, —OC(=O)R27, and —C(=O)R28, and of R22, R23, R24, R25, R26, R27, and R28 is independently selected from the group consisting of hydrogen, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C3-7carbocyclyl, C6-10aryl, 5-10 membered heteroaryl, and 3-10 membered heterocyclyl.